UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical experience with Idebenone (Raxone®) in the treatment of patients with Leber's Hereditary Optic Neuropathy (LHON)

Acta ophthalmologica (Oxford, England), 2015-10, Vol.93 (S255), p.n/a

2015

Volltextzugriff (PDF)

Morphological and Clinical Characterization of Foveal Bulge Sign Three Years After Retinal Detachment Repair: A Longitudinal Prospective Evaluation

Clinical ophthalmology (Auckland, N.Z.), 2024-08, Vol.18, p.2261-2270

2024

Volltextzugriff (PDF)

Maintained treatment with idebenone increases the probability and magnitude of visual acuity recovery in patients with Leber's hereditary optic neuropathy (LHON)

Acta ophthalmologica (Oxford, England), 2018-12, Vol.96 (S261), p.74-74

2018

Volltextzugriff (PDF)

Idebenone Is Effective and Well Tolerated in Leber’s Hereditary Optic Neuropathy (LHON): Results of a 3-Year Expanded Access Program (S48.005)

Neurology, 2016, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

Incidence of retinal vein occlusion during the football World Cup in 2014 : A database analysis

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2016-09, Vol.113 (9), p.763-766

2016

Volltextzugriff (PDF)

Clinical experience with Raxone® (Idebenone) in the treatment of patients with Leber’s hereditary optic neuropathy (LHON)

Acta ophthalmologica (Oxford, England), 2014-09, Vol.92 (s253), p.0-0

2014

Volltextzugriff (PDF)

Inzidenz von Zentralvenen- und Venenastverschlüssen während der Fußballweltmeisterschaft 2014: Eine Datenbankanalyse

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2016-09, Vol.113 (9), p.763-766

2016

Volltextzugriff (PDF)

6.89 DEFINING SYMPTOM DIMENSIONS AND SUBTYPES IN CHILDHOOD-ONSET SCHIZOPHRENIA

Journal of the American Academy of Child and Adolescent Psychiatry, 2016, Vol.55 (10), p.S233-S233

2016

Volltextzugriff (PDF)

Walking The Balance Beam: Markets are extraordinarily volatile, and anxiety is still high - but now is an appropriate time for investors to move up to their long-term equity targets

Trusts & Estates, 2011-01, Vol.150 (1), p.11

2011

Volltextzugriff (PDF)

Lässt sich der Qualitätsbegriff "Schweiz" auf Bekleidung übertragen?

Elégance suisse, 1974 (2), p.9

Loeb, F

1974

Volltextzugriff (PDF)

Z-Sampler for outpatient diagnosis of endometrial sampling

International journal of gynecology and obstetrics, 1992-12, Vol.39 (4), p.336-337

1992

Volltextzugriff (PDF)

Reminiscences of a visit to the KREHL Clinic in 1928

Munchener medizinische Wochenschrift (1950), 1961-12, Vol.103, p.2497

LOEB, R F

1961

Volltextzugriff (PDF)

Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3606-3610

2015

Volltextzugriff (PDF)

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019

BMC microbiology, 2021-03, Vol.21 (1), p.74-74, Article 74

2021

Volltextzugriff (PDF)

In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes—Study for Monitoring Antimicrobial Resistance Trends, United States 2015–2017

Clinical infectious diseases, 2021-06, Vol.72 (12), p.2112-2120

2021

Volltextzugriff (PDF)

In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)

Antimicrobial agents and chemotherapy, 2017-06, Vol.61 (6)

2017

Volltextzugriff (PDF)

Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii

International journal of antimicrobial agents, 2016-04, Vol.47 (4), p.317-323

2016

Volltextzugriff (PDF)

In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014

Journal of clinical microbiology, 2017-06, Vol.55 (6), p.1638-1649

2017

Volltextzugriff (PDF)

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020

European journal of clinical microbiology & infectious diseases, 2023-03, Vol.42 (3), p.365-370

2023

Volltextzugriff (PDF)

Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014

Diagnostic microbiology and infectious disease, 2016-08, Vol.85 (4), p.459-465

2016

Volltextzugriff (PDF)

In vitro activity of imipenem-relebactam against resistant phenotypes of Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples - SMART Surveillance Europe 2015-2017

Journal of medical microbiology, 2020-02, Vol.69 (2), p.207-217

2020

Volltextzugriff (PDF)

Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020

International journal of infectious diseases, 2022-12, Vol.125, p.250-257

2022

Volltextzugriff (PDF)

Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019

International journal of antimicrobial agents, 2022-03, Vol.59 (3), p.106535-106535, Article 106535

2022

Volltextzugriff (PDF)

In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme

Journal of antimicrobial chemotherapy, 2018-07, Vol.73 (7), p.1872-1879

2018

Volltextzugriff (PDF)

Activity of imipenem/relebactam against MDR Pseudomonas aeruginosa in Europe: SMART 2015-17

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (8), p.2284-2288

2019

Volltextzugriff (PDF)

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(76)
Humans
(50)
Infectious Diseases
(34)
Microbiology
(33)
Smart
(30)
Pharmacology & Pharmacy
(23)
Surveillance
(23)
Female
(18)
Anti-Bacterial Agents - Pharmacology
(17)
Male
(17)
Poster Abstracts
(17)
Microbial Sensitivity Tests
(16)
Pseudomonas Aeruginosa
(15)
Adult
(14)
United States
(14)
Surgery
(12)
Imipenem
(11)
Gram-Negative Bacilli
(10)
Middle Aged
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical experience with Idebenone (Raxone®) in the treatment of patients with Leber's Hereditary Optic Neuropathy (LHON)

Morphological and Clinical Characterization of Foveal Bulge Sign Three Years After Retinal Detachment Repair: A Longitudinal Prospective Evaluation

Maintained treatment with idebenone increases the probability and magnitude of visual acuity recovery in patients with Leber's hereditary optic neuropathy (LHON)

Idebenone Is Effective and Well Tolerated in Leber’s Hereditary Optic Neuropathy (LHON): Results of a 3-Year Expanded Access Program (S48.005)

Incidence of retinal vein occlusion during the football World Cup in 2014 : A database analysis

Clinical experience with Raxone® (Idebenone) in the treatment of patients with Leber’s hereditary optic neuropathy (LHON)

Inzidenz von Zentralvenen- und Venenastverschlüssen während der Fußballweltmeisterschaft 2014: Eine Datenbankanalyse

6.89 DEFINING SYMPTOM DIMENSIONS AND SUBTYPES IN CHILDHOOD-ONSET SCHIZOPHRENIA

Walking The Balance Beam: Markets are extraordinarily volatile, and anxiety is still high - but now is an appropriate time for investors to move up to their long-term equity targets

Lässt sich der Qualitätsbegriff "Schweiz" auf Bekleidung übertragen?

Z-Sampler for outpatient diagnosis of endometrial sampling

Reminiscences of a visit to the KREHL Clinic in 1928

Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019

In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes—Study for Monitoring Antimicrobial Resistance Trends, United States 2015–2017

In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)

Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii

In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020

Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014

In vitro activity of imipenem-relebactam against resistant phenotypes of Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples - SMART Surveillance Europe 2015-2017

Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020

Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019

In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme

Activity of imipenem/relebactam against MDR Pseudomonas aeruginosa in Europe: SMART 2015-17

Suchergebnisse filtern